New evidence shows depression linked to circadian rhythm
Depression is a mood disorder that can bring a wide range of emotional and physical problems. It is marked by …
Post
-
-
Influenza mortality in hospitalised patients affected by vaccination
Annually, seasonal influenza is responsible for between 3 and 5 million severe illnesses and 290,000–650,000 respiratory deaths worldwide. An October …
-
ESMO26: MSD and Moderna drop cancer vaccine trial data early
MSD and Moderna have reported full Phase III results for their personalised cancer vaccine, but both companies’ shares fell after …
-
AbbVie’s skin disease drug posts Phase III win as market competition heats up
AbbVie’s hidradenitis suppurativa (HS) candidate lutikizumab has demonstrated its potential to significantly reduce flares of the disease, though a the …
-
Prilenia and Ferrer secure EU authorisation for Phase III HD trial
Prilenia Therapeutics and Ferrer have secured EU authorisation to begin PRECISE-HD, a confirmatory Phase III trial of pridopidine to treat Huntington’s …
-
Granata Bio concludes screening in Phase III GRACE trial for IVF
Granata Bio has completed participant screening in its Phase III GRACE trial of Granata Bio human menopausal gonadotropin (GB-hMG) in …
-
Roivant eyes Lisraya label expansion on Phase III uveitis win
Roivant and its subsidiary, Priovant Therapeutics, have scored another late-stage win for their marketed ophthalmology therapy, Lisraya (brepocitinib), in non-infectious …
-
HealthBio begins multi-centre trial of Inflamexa for PTLDS
US-based biotechnology company HealthBio has initiated a multi-centre clinical trial, HBT-002, to assess its lead compound Inflamexa in adult patients …
-
Podcast: Do PI signatures really signal meaningful oversight?
As clinical trial oversight has moved online as technology is more utilised in clinical trials, it brings up some questions …
-
Lynch’s rhPDGF-BB IND secures FDA clearance for Phase II trial
The US Food and Drug Administration (FDA) has authorised Lynch Regenerative Medicine’s investigational new drug (IND) application for a Phase …
-
Covid-19 and international aid cuts disrupt tuberculosis care in South Africa
South Africa suffers from a disproportionately severe disease burden of tuberculosis (TB), which is one of the country’s leading causes …
-
Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial
Sanofi and Teva Pharmaceuticals’ inflammatory bowel disease (IBD) drug has shown benefit in patients with both ulcerative colitis (UC) and …
-
Amgen and AstraZeneca report Phase III Tezspire data for EoE
Amgen and AstraZeneca have reported complete results from the Phase III CROSSING clinical trial of Tezspire (tezepelumab-ekko) for adolescent and …
-
Shionogi and F2G’s invasive aspergillosis drug shows long-term benefit
Shionogi and F2G are releasing further data from a non-inferiority study of the latter's oral invasive aspergillosis drug, showing its …
-
AstraZeneca and Oracle collaborate to test AI in clinical trial recruitment
AstraZeneca and Oracle have signed a non-binding agreement to investigate how AI and real-world data can help medical teams recruit …
